Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Share News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

Share Price is delayed by 15 minutes
Get Live Data
322.00    0.00 (0.00%)
Bid:
325.50
Ask:
330.00
Spread: 4.50 (1.382%)
Market Cap: £104.30m
ACSO Live PriceLast checked at - London Stock Exchange

Intraday Accesso Technology Group Share Chart

Wednesday broker round-up

Wed, 07th Jul 2021 14:03
(Sharecast News) - WM Morrison: Berenberg downgrades to hold with a target price of 254p.



Barclays: Berenberg reiterates buy with a target price of 220p.

Aston Martin: Citigroup reiterates buy with a target price of 2,800p.

Segro: JP Morgan reiterates neutral with a target price of 1,195p.

Sainsbury: Barclays reiterates overweight with a target price of 305p.

GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.

On The Beach: Liberum reiterates hold with a target price of 380p.

888 Holdings: Peel Hunt reiterates buy with a target price of 500p.

Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.

Redrow: Numis reiterates buy with a target price of 715p.

Accesso: Numis upgrades to buy with a target price of 800p.

International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.

Centrica: Credit Suisse reiterates outperform with a target price of 70p.

Related News

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
21 hours ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
23 hours ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

GSK hails 'milestone' drug trial results in China
1 day ago

GSK hails 'milestone' drug trial results in China

(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...

Accesso Technology Group News

LONDON BROKER RATINGS: Panmure Liberum raises AB Foods to 'buy'
14 Jul 2025

LONDON BROKER RATINGS: Panmure Liberum raises AB Foods to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

AIM WINNERS & LOSERS: Rockfire up on Plateau drilling; accesso slumps
11 Jul 2025

AIM WINNERS & LOSERS: Rockfire up on Plateau drilling; accesso slumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

Accesso flags revenue at low end of forecasts, customer non-renewal
11 Jul 2025

Accesso flags revenue at low end of forecasts, customer non-renewal

(Sharecast News) - Accesso Technology said in an update on Friday that it expects full-year revenue for 2025 to come in at the lower end of its guidan...

accesso shares drop as it sees 2025 revenue at low end of guidance
11 Jul 2025

accesso shares drop as it sees 2025 revenue at low end of guidance

(Alliance News) - accesso Technology Group PLC on Friday said revenue for 2025 is likely to come in at the lower end of guidance due to weaker-than-ex...

LONDON MARKET OPEN: Europe makes slow start on tariff nerves
11 Jul 2025

LONDON MARKET OPEN: Europe makes slow start on tariff nerves

(Alliance News) - Stock prices in Europe were lower early Friday, with the FTSE 100 suffering a marginal fall after achieving another record high.

Peel Hunt downgrades Accesso Technology to 'hold'
4 Jul 2025

Peel Hunt downgrades Accesso Technology to 'hold'

(Sharecast News) - Peel Hunt downgraded Accesso Technology on Friday to 'hold' from 'buy' as it pointed to falling foot traffic.

Berenberg starts coverage of Accesso Technology at 'buy'
20 May 2025

Berenberg starts coverage of Accesso Technology at 'buy'

(Sharecast News) - Berenberg initiated coverage of Accesso Technology on Tuesday with a 'buy' rating and 775p price target.

LONDON BRIEFING: Vodafone announces buyback; Diploma ups outlook
20 May 2025

LONDON BRIEFING: Vodafone announces buyback; Diploma ups outlook

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, having perked up as Monday wore on, shaking off a tough start to the week aft...